Botulinum Toxin in Urology Market
According to Intent Market Research, the Botulinum Toxin in Urology Market is expected to grow from USD 0.9 Billion in 2024-e at a CAGR of 7.6% to touch USD 1.4 Billion by 2030. The Botulinum Toxin in Urology Market is dominated by key players such as, Allergan (AbbVie Inc.), Medytox, Revance Therap... Read More